Rumored Buzz on Healthcare News
Novo CEO pressed by Senate to chop selling prices of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporate would think about new talks with insurers about the record price ranges of Wegovy and copyright if they pledge to help keep the medicines on their formularies.Previously this summertime, the firm held